BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering

Core Viewpoint - BioXcel Therapeutics, Inc. has announced a public offering of common stock and warrants, aiming to raise approximately $7.0 million before expenses [1][3]. Group 1: Offering Details - The company is offering 5,600,000 shares of common stock and accompanying warrants, with a public offering price of$0.48 per share [1]. - For certain investors, pre-funded warrants to purchase up to 9,000,000 shares are also available, priced at $0.479 per share [1]. - Each accompanying warrant will have an exercise price of$0.48 and will expire five years after issuance [2]. Group 2: Underwriting and Closing - Canaccord Genuity is acting as the sole book-running manager for the public offering [3]. - The offering is expected to close on or about November 25, 2024, subject to customary closing conditions [3]. Group 3: Regulatory Compliance - The securities are being offered under a shelf registration statement filed with the SEC, which became effective on November 13, 2023 [4]. - A preliminary prospectus supplement has been filed with the SEC and is available on their website [4].